Jens Kollmeier

机构：Helios Klinikum Emil von Behring, Institut für Lungenforschung · ORCID：0000-0002-8048-3895

发表论文 230 篇 · 总被引 3112 次 · h-index 29

代表论文

• Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer (2023 · Journal of Thoracic Oncology · 被引 49)
• Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 (2024 · Scientific Reports · 被引 28)
• Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis (2023 · Lung Cancer · 被引 19)
• Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies (2023 · International Journal of Molecular Sciences · 被引 13)
• Cell‐free DNA extraction from urine of lung cancer patients and healthy individuals: Evaluation of a simple method using sample volume up‐scaling (2023 · Journal of Clinical Laboratory Analysis · 被引 10)
• Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms (2023 · Pneumologie · 被引 9)